Abstract:Results from previous studies on the role of autophagy of β‐cell function together with its implication in the development of diabetes are discussed. As β‐cell failure is an ultimate cause of diabetes and also that of unresponsiveness to the conventional therapy, modulation of β‐cell autophagy could be a future antidiabetic modality, particularly for patients who are not well managed with current antidiabetic therapy. Elucidating the molecular mechanism of autophagy was a landmark in understanding not only the physiology of cells and tissues, but also the pathogenesis of diverse diseases, including diabetes and metabolic disorders. Autophagy of pancreatic β‐cells plays a pivotal role in the maintenance of the mass, structure and function of β‐cells, whose dysregulation can lead to abnormal metabolic profiles or diabetes. Modulators of autophagy are being developed to improve metabolic profile and β‐cell function through the removal of harmful materials and rejuvenation of organelles, such as mitochondria and endoplasmic reticulum. Among the known antidiabetic drugs, glucagon‐like peptide‐1 receptor agonists enhance the autophagic activity of β‐cells, which might contribute to the profound effects of glucagon‐like peptide‐1 receptor agonists on systemic metabolism. In this review, the results from studies on the role of autophagy in β‐cells and their implication in the development of diabetes are discussed. In addition to non‐selective (macro)autophagy, the role and mechanisms of selective autophagy and other minor forms of autophagy that might occur in β‐cells are discussed. As β‐cell failure is the ultimate cause of diabetes and unresponsiveness to conventional therapy, modulation of β‐cell autophagy might represent a future antidiabetic treatment approach, particularly in patients who are not well managed with current antidiabetic therapy.

Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes

The Role of Fatty Acid Metabolism and Lipotoxicity in Pancreatic Β-Cell Injury: Identification of Potential Therapeutic Targets

Fatty Acid and Lipopolysaccharide Effect on Beta Cells Proteostasis and its Impact on Insulin Secretion

Fatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells During Development of Type 2 Diabetes

Mechanisms of lipotoxicity‐induced dysfunction and death of human pancreatic beta cells under obesity and type 2 diabetes conditions

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Free fatty acids accelerate β-cell death in type 1 diabetes

The fate of intracellular S1P regulates lipid droplet turnover and lipotoxicity in pancreatic beta-cells

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Mechanisms of Oleic Acid Deterioration in Insulin Secretion: Role in the Pathogenesis of Type 2 Diabetes

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction

Targeting fatty acid metabolism to improve glucose metabolism

An adipocentric perspective of pancreatic lipotoxicity in diabetes pathogenesis

Role of β‐cell autophagy in β‐cell physiology and the development of diabetes

Persistent Inflammatory Lipotoxicity Impedes Pancreatic β-cell Function in Diet-Induced Obese Mice Despite Correction of Glucotoxicity

Beta cell response to nutrient overload involves phospholipid remodelling and lipid peroxidation

β-Cell Insulin Resistance Plays a Causal Role in Fat-Induced β-Cell Dysfunction In Vitro and In Vivo

Metabolic Stress and Compromised Identity of Pancreatic Beta Cells

Role of the Gut Microbiome in Beta Cell and Adipose Tissue Crosstalk: A Review

Metabolic and functional specialisations of the pancreatic beta cell: gene disallowance, mitochondrial metabolism and intercellular connectivity